Navigation Links
Dirty Drugs and We Know It: Attorneys at Console & Hollawell Comment on ISMP Survey Relating to Contaminated Drug Compounds and the Risks to Consumers

Marlton, NJ (PRWEB) February 08, 2013

Many supposed ‘sterile’ drugs are often contaminated, according to a new survey of hospital pharmacists conducted by the Institute for Safe Medication Practices (ISMP). The report, highlighted in a recent article by NBC News, says 13 percent of pharmacists and pharmacy technicians believe contamination of compounded sterile drugs occurred in their shops in 2012. These are the same class of medications that reportedly caused the deaths of 45 people across the country and led to 700 infections from fungal meningitis. In New Jersey, where more than a dozen patients died after receiving injections of tainted steroid compound, personal injury attorney Richard P. Console Jr. sees the potential for another serious outbreak.

“Compromised facilities are endangering the lives of patients everywhere,” he said. “The Food and Drug Administration needs to step up inspections and enforcement actions to prevent the next New England Compounding Center from distributing a batch of infected product. These compounds are supposed to help people, not put their lives in jeopardy.”

The majority of pharmacists surveyed had little to no confidence that contamination at their facilities were completely free of contamination during the year, according to NBC News. Almost 75 percent of all healthcare professionals participating in the ISMP study reportedly said conditions for the contamination of sterile drug compounds could exist at their sites. Compounding centers have come under increasing fire in the last year after conditions at facilities owned by the New England Compounding Center lead to a nationwide fungal meningitis outbreak. The company has since shuttered its doors.

Compounding centers take existing medications from actual pharmaceutical manufacturers and combine them to create new materials. While the Food and Drug Administration (FDA) does not regulate these centers as it does pharmaceutical manufacturers, the federal government has moved to inspect their facilities more closely in light of the widespread meningitis infections. This move overlays current inspection and regulation duties, which state authorities are supposed to handle. Console, whose firm has represented more than 5,000 clients, doesn’t believe the measures go far enough to protect consumers.

“If we were doing enough to protect patients from harm, we wouldn’t have pharmacists and doctors saying sterile medications are still being contaminated,” he said. “Aggressive pursuit of compounding centers that sell contaminated drugs and allow deplorable conditions to exist at their facilities is necessary to curtail the behavior. The victims and their families deserve compensation. Civil suits are sometimes the only way to make these industries change their ways.”

Richard P. Console Jr. managing partner of Console & Hollawell P.C., has been a personal injury lawyer in New Jersey since 1994. His firm has obtained more than $30,000,000 in compensation for injured victims, including those who have suffered due to the actions of negligence manufacturers and healthcare providers.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dirty Pacifiers May Make Infants Sick: Study
2. No Evidence That Lupus Drugs Lead to Cancer, Says Study
3. Glazer receives grant to study light-activated cancer drugs
4. Hops, Key to Flavor in Beer, May Prove Useful in New Drugs
5. No Proof Drugs Ease Kids Migraines: Study
6. FDA Approves 3 New Drugs for Type 2 Diabetes
7. Do non-steroidal anti-inflammatory drugs cause kidney failure in children?
8. Research: Lupus drugs carry no significant cancer risk for patients
9. Hearing-loss-prevention drugs closer to reality thanks to new UF test
10. Scientists find a new way to boost common cancer drugs
11. UGA discovery promises to improve drugs used to fight cancer, other diseases
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 ... brings up a new, often overlooked aspect of head lice: the parasite’s ability to live ... not a common occurrence, but a necessary one in the event that lice have simply ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology: